The federal landscape has made access to transgender medical care increasingly uncertain for patients and providers alike. Executive orders, proposed regulatory changes and politically motivated enforcement actions have created a climate in which patients cannot assume that their current access to care will continue uninterrupted.

While prescriptions may allow patients to pick up many months’ worth of refills at once, many insurers only cover the cost of the medication if patients pick up refills more slowly over time. To get a medication supply that will last for a longer period, patients often need to pay out-of-pocket. For many patients and their families, this is financially burdensome or simply not possible.

GLAD Law submitted testimony in support of H8245 and S2863, legislation that would ensure coverage for supplies of hormone prescriptions for up to 12 months. This legislation would ensure that patients have a stop-gap option for continuity of treatment, in the event of an interruption to their access to medically necessary medications. Read our testimony on H8245 and S2863 to learn more.